Effect of food on the bioavailability of low‐dose methotrexate in patients with rheumatoid arthritis

Arthritis & Rheumatism

Volumn 35, Issue 6, 1992, Pages 611-614

  Oguey, D ^a   Kolliker F ^a   Gerber, N J ^a   Reichen, J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; FEMALE; FOOD DRUG INTERACTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ABSORPTION; ADMINISTRATION, ORAL; AGED; ARTHRITIS, RHEUMATOID; BIOLOGICAL AVAILABILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOOD; HUMANS; MALE; METHOTREXATE; MIDDLE AGED;

EID: 0026710176     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780350603     Document Type: Article

References (15)

1. Efficacy of low dose methotrexate in rheumatoid arthritis
2. Clinical pharmacokinetics of methotrexate
3. Low‐dose methotrexate kinetics in arthritis
4. Pharmacokinetics of low‐dose methotrexate in rheumatoid arthritis patients
5. Methotrexate pharmacokinetics in patients with rheumatoid arthritis
6. Can food influence the absorption of methotrexate in children with acute lymphoblastic leukemia?
7. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
8. Evaluation of fluorescence polarization immunoassay procedure for quantitation of methotrexate
9. Effect of oral prophylactic broad spectrum nonabsorbable antibiotics on the gastrointestinal absorption of nutrients and methotrexate in small cell bronchogenic carcinoma patients
10. The bioavailability of oral intermediate‐dose methotrexate: effect of dose subdivision, formulation and timing in the chemotherapy cycle
11. The metabolic fate of tritiated methotrexate. II. Absorption and excretion in man
12. Comparison of serum methotrexate concentrations after various routes of administration
13. Drug‐drug interactions with antirheumatic agents: review of selected clinically important interactions